Lanxia Liu

1.2k total citations
41 papers, 955 citations indexed

About

Lanxia Liu is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Lanxia Liu has authored 41 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Immunology and 12 papers in Biomedical Engineering. Recurrent topics in Lanxia Liu's work include RNA Interference and Gene Delivery (17 papers), Immunotherapy and Immune Responses (13 papers) and Advanced biosensing and bioanalysis techniques (10 papers). Lanxia Liu is often cited by papers focused on RNA Interference and Gene Delivery (17 papers), Immunotherapy and Immune Responses (13 papers) and Advanced biosensing and bioanalysis techniques (10 papers). Lanxia Liu collaborates with scholars based in China, United States and United Kingdom. Lanxia Liu's co-authors include Xigang Leng, Guilei Ma, Dunwan Zhu, Hongfan Sun, Xia Dong, Hailing Zhang, Cunxian Song, Deling Kong, Deling Kong and Mengmeng Yan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Applied Materials & Interfaces.

In The Last Decade

Lanxia Liu

38 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanxia Liu China 19 434 399 366 246 140 41 955
Simon Van Herck Belgium 16 357 0.8× 307 0.8× 402 1.1× 234 1.0× 85 0.6× 33 941
Maya Holay United States 14 490 1.1× 580 1.5× 334 0.9× 256 1.0× 104 0.7× 16 1.1k
Carina Peres Portugal 10 294 0.7× 315 0.8× 326 0.9× 256 1.0× 107 0.8× 20 840
Torben Knuschke Germany 17 392 0.9× 251 0.6× 365 1.0× 194 0.8× 85 0.6× 27 905
Guilei Ma China 20 361 0.8× 530 1.3× 433 1.2× 454 1.8× 116 0.8× 37 1.2k
Annemie Rehor Switzerland 12 335 0.8× 274 0.7× 370 1.0× 245 1.0× 118 0.8× 14 1.1k
Elana Ben‐Akiva United States 12 539 1.2× 423 1.1× 194 0.5× 419 1.7× 100 0.7× 25 1.1k
Huapan Fang China 19 448 1.0× 498 1.2× 255 0.7× 266 1.1× 127 0.9× 43 1.1k
Roberto Palomba Italy 18 610 1.4× 480 1.2× 238 0.7× 457 1.9× 170 1.2× 32 1.4k

Countries citing papers authored by Lanxia Liu

Since Specialization
Citations

This map shows the geographic impact of Lanxia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanxia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanxia Liu more than expected).

Fields of papers citing papers by Lanxia Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanxia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanxia Liu. The network helps show where Lanxia Liu may publish in the future.

Co-authorship network of co-authors of Lanxia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Lanxia Liu. A scholar is included among the top collaborators of Lanxia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanxia Liu. Lanxia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Minghua, et al.. (2025). MWCNTs-OH-modified AgInS2 for highly efficient visible-light degradation of gaseous formaldehyde. Diamond and Related Materials. 157. 112571–112571.
2.
Lin, Xiaoling, Weixiao Wang, Lanxia Liu, et al.. (2025). Gastrointestinal cytomegalovirus infection in persons with HIV: a retrospective case series study. BMC Infectious Diseases. 25(1). 506–506.
3.
Deng, Bo, et al.. (2025). A novel carrier-free nanoparticle with stable distinctive three-dimensional structure for tumor-targeted precision chemoimmunotherapy. Journal of Nanobiotechnology. 23(1). 480–480. 2 indexed citations
4.
5.
Ma, Yue, Jialyu Huang, Miaomiao Luo, et al.. (2024). Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes. Science Advances. 10(23). eado1550–eado1550. 12 indexed citations
6.
Ma, Yingying, et al.. (2023). Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy. Journal of Nanobiotechnology. 21(1). 171–171. 18 indexed citations
7.
Ma, Yingying, Pei Cao, Xigang Leng, et al.. (2022). Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment. Journal of Nanobiotechnology. 20(1). 140–140. 31 indexed citations
8.
9.
Zhang, Jing, Dan Liu, Jiale Liu, et al.. (2020). Hybrid spherical nucleotide nanoparticles can enhance the synergistic anti-tumor effect of CTLA-4 and PD-1 blockades. Biomaterials Science. 8(17). 4757–4766. 15 indexed citations
10.
Qin, Yu, Zhiming Zhang, Chenlu Huang, et al.. (2018). Folate-Targeted Redox-Responsive Polymersomes Loaded with Chemotherapeutic Drugs and Tariquidar to Overcome Drug Resistance. Journal of Biomedical Nanotechnology. 14(10). 1705–1718. 20 indexed citations
11.
Liu, Xiaoxuan, Lin Zhu, Jingjing Ma, et al.. (2016). Target-specific delivery of siRNA into hepatoma cells’ cytoplasm by bifunctional carrier peptide. Drug Delivery and Translational Research. 7(1). 147–155. 3 indexed citations
12.
Liu, Lanxia, Hai Wang, Chao Zhang, et al.. (2016). Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles. Journal of Controlled Release. 225. 230–239. 87 indexed citations
13.
Liu, Qi, Lanxia Liu, Guilei Ma, et al.. (2016). Evaluation of PLGA containing anti -CTLA4 inhibited endometriosis progression by regulating CD4 + CD25 + Treg cells in peritoneal fluid of mouse endometriosis model. European Journal of Pharmaceutical Sciences. 96. 542–550. 36 indexed citations
14.
Liu, Lanxia, Xia Dong, Dunwan Zhu, et al.. (2014). TAT-LHRH conjugated low molecular weight chitosan as a gene carrier specific for hepatocellular carcinoma cells. International Journal of Nanomedicine. 9. 2879–2879. 28 indexed citations
15.
Zhu, Xiaoyun & Lanxia Liu. (2013). [Ultrastructure of hepatocytes in Gilbert's syndrome patients and chronic hepatitis B patients].. PubMed. 21(12). 929–33. 1 indexed citations
16.
Zhang, Hailing, Dunwan Zhu, Liping Song, et al.. (2011). Arginine conjugation affects the endocytic pathways of chitosan/DNA nanoparticles. Journal of Biomedical Materials Research Part A. 98A(2). 296–302. 24 indexed citations
17.
Song, Liping, Dunwan Zhu, Lanxia Liu, et al.. (2010). Evaluation of the coagulation properties of arginine‐chitosan/DNA nanoparticles. Journal of Biomedical Materials Research Part B Applied Biomaterials. 95B(2). 374–379. 14 indexed citations
18.
Dong, Xia, Liping Song, Dunwan Zhu, et al.. (2010). Tissue factor pathway inhibitor suppresses the growth of human vascular smooth muscle cells through regulating cell cycle. Molecular Biology Reports. 38(7). 4771–4776. 1 indexed citations
19.
Zhu, Dunwan, Kangde Yao, Hailing Zhang, et al.. (2009). Hydrophilic/lipophilic N-methylene phosphonic chitosan as a promising non-viral vector for gene delivery. Journal of Materials Science Materials in Medicine. 21(1). 223–229. 12 indexed citations
20.
Jin, Xu, Lin Mei, Cunxian Song, et al.. (2008). Immobilization of plasmid DNA on an anti‐DNA antibody modified coronary stent for intravascular site‐specific gene therapy. The Journal of Gene Medicine. 10(4). 421–429. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Van Herck Breakdown of academic impact, for papers by Maya Holay Breakdown of academic impact, for papers by Carina Peres Breakdown of academic impact, for papers by Torben Knuschke Breakdown of academic impact, for papers by Guilei Ma Breakdown of academic impact, for papers by Annemie Rehor Breakdown of academic impact, for papers by Elana Ben‐Akiva Breakdown of academic impact, for papers by Huapan Fang Breakdown of academic impact, for papers by Roberto Palomba
Rankless by CCL
2026